The firm’s unique governance structure, with over 40% employee ownership, fosters an entrepreneurial spirit and allows for strategic investments during industry downturns. A disciplined approach to private equity, particularly in technology and life sciences, has enabled the team to navigate elevated valuations effectively. This long-term focus and alignment with clients' interests are seen as key advantages in a competitive investment landscape.
